Andrew Donlan

Addus HomeCare Corp. (Nasdaq: ADUS) leaders still believe the Medicaid Access Rule missed the mark. But that doesn’t mean they won’t take advantage of

Enhabit Inc. (NYSE: EHAB) has completed its strategic review, which was first announced in August of last year. Ultimately, the company’s board has

Enhabit Inc. (NYSE: EHAB) announced Wednesday the result of its strategic review. It was not a sale or a merger, but instead a commitment to the path

The Medicaid Access Rule has been finalized, with six years until the implementation of the 80-20 provision. There’s no time to rest for home-based care

Home-based care dealmakers have been busier of late, but that has not yet translated into more transactions.

Jim Rechtin, who was named Bruce Broussard’s successor at Humana Inc. (NYSE: HUM) in October of last year, will officially take over on July 1, the company announced Monday.

Aveanna Healthcare Holdings (Nasdaq: AVAH) leaders believe the company is back at a place where it can bank on near-term growth in its Medicare-certified home health business.

The Pennant Group (Nasdaq: PNTG) has had to adjust to Medicare Advantage (MA) penetration in home health care, just like its peers. Unlike its peers, however, its adjustments have been mostly smooth sailing.

If there were ever a time for Medicare Advantage-related troubles to cool off in the home health care space, now would be it. And, heading into the

The Pennant Group secures 2 more acquisitions The Pennant Group has completed two acquisitions thus far in May. Announced first was its